search
Back to results

Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease

Primary Purpose

Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
Nebulizer
Breathing Technique
Sponsored by
Riphah International University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease focused on measuring Pranayama, COPD, Dyspnea, Exercise tolerance

Eligibility Criteria

30 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Both gender of age group 30 to 55 Patient with diagnosed COPD. Moderate to severe COPD. Patient with productive cough and SOB. No surgical procedure perform. Exclusion Criteria: Patient of lung surgery Lung cancer patient Patient above 70 years age. Patient with open wound. Patient with cardiovascular issues

Sites / Locations

  • Bahawal Victoria Hospital and Civil Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Pranayma Breathing Technique

Conventional Treatment

Arm Description

Pranayma Breathing Technique protocol includes 15 breaths in the morning and 15 breaths in evening for atleast weeks.

Long-acting beta-2 agonist, nebulizers and long acting anti-mucosic drugs.

Outcomes

Primary Outcome Measures

6 min walk test.
The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
IPAQ- quality of life
The International Physical Activity Questionnaire (IPAQ) will be used to evaluate the current physical activity level of the participants.
VSAQ-exercise capacity
The VSAQ, capturing patient-reported outcome measures, is an efficient and quantifiable measure of exercise capacity that can be readily employed in clinical services particularly where patients have normal to high exercise tolerance

Secondary Outcome Measures

Full Information

First Posted
December 6, 2022
Last Updated
February 20, 2023
Sponsor
Riphah International University
search

1. Study Identification

Unique Protocol Identification Number
NCT05651958
Brief Title
Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease
Official Title
Effects of Pranayama Breathing Technique on Dyspnea, Exercise Tolerance and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
February 1, 2022 (Actual)
Primary Completion Date
January 31, 2023 (Actual)
Study Completion Date
January 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Riphah International University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
It will be randomized controlled trial. The research will be conducted at Bahawal Victoria hospital Bahawalpur and civil hospital Bahawalpur. We take 60 patients (Epitool), Patients will be allocated randomly in two groups. Group A will get conventional medical treatment and Group B will get both conventional medical treatment and pranayama breathing exercise. Both gender of age group 30 to 55, Patient with diagnosed Chronic obstructive pulmonary disease ,Moderate to severe Chronic obstructive pulmonary disease with productive cough, Shortness of breathe and no surgical procedure performed will be included in this study. And patients of lung surgery, lung cancer, above 70 years age, with open wound, cardiovascular issues, and neurological issues will be excluded. Yoga exercise pranayama, 6 min walk test, IPAQ- quality of life and VSAQ-exercise capacity will be used as tools. Data will be analyzed on SPSS 21.
Detailed Description
It will be randomized controlled trial. After approval of synopsis the research will be conducted at Bahawal Victoria hospital Bahawalpur and Sadiq abbasi hospital Bahawalpur. Written informed consent will be obtained. We take 60 patients (Epitool), Patients will be allocated randomly in two groups. Group A and group B. Group A will get conventional medical treatment and Group B will get both conventional medical treatment and pranayama breathing exercise. Both gender of age group 30 to 55, Patient with diagnosed COPD, Moderate to severe COPD with productive cough, SOB and no surgical procedure performed will be included in this study. And patients of lung surgery, lung cancer, above 70 years age, with open wound, cardiovascular issues, and neurological issues will be excluded. Yoga exercise pranayama, 6 min walk test, IPAQ- quality of life and VSAQ-exercise capacity will be used as tools. Data will be analyzed on SPSS 21.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
Pranayama, COPD, Dyspnea, Exercise tolerance

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
42 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Pranayma Breathing Technique
Arm Type
Experimental
Arm Description
Pranayma Breathing Technique protocol includes 15 breaths in the morning and 15 breaths in evening for atleast weeks.
Arm Title
Conventional Treatment
Arm Type
Active Comparator
Arm Description
Long-acting beta-2 agonist, nebulizers and long acting anti-mucosic drugs.
Intervention Type
Other
Intervention Name(s)
Nebulizer
Intervention Description
Active Comparator: Nebulization every 3 days with the other medicine to the active comparator.
Intervention Type
Other
Intervention Name(s)
Breathing Technique
Intervention Description
15 repeatations of Breathing in morning and evening
Primary Outcome Measure Information:
Title
6 min walk test.
Description
The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Time Frame
Six Weeks
Title
IPAQ- quality of life
Description
The International Physical Activity Questionnaire (IPAQ) will be used to evaluate the current physical activity level of the participants.
Time Frame
Six Weeks
Title
VSAQ-exercise capacity
Description
The VSAQ, capturing patient-reported outcome measures, is an efficient and quantifiable measure of exercise capacity that can be readily employed in clinical services particularly where patients have normal to high exercise tolerance
Time Frame
Six Weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Both gender of age group 30 to 55 Patient with diagnosed COPD. Moderate to severe COPD. Patient with productive cough and SOB. No surgical procedure perform. Exclusion Criteria: Patient of lung surgery Lung cancer patient Patient above 70 years age. Patient with open wound. Patient with cardiovascular issues
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
madiha younas, MS
Organizational Affiliation
riphah internationl university
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bahawal Victoria Hospital and Civil Hospital
City
Bahāwalpur
State/Province
Punjab
ZIP/Postal Code
63100
Country
Pakistan

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease

We'll reach out to this number within 24 hrs